• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis.

作者信息

Williams Roger, Aspinall Richard, Bellis Mark, Camps-Walsh Ginette, Cramp Matthew, Dhawan Anil, Ferguson James, Forton Dan, Foster Graham, Gilmore Ian, Hickman Matthew, Hudson Mark, Kelly Deirdre, Langford Andrew, Lombard Martin, Longworth Louise, Martin Natasha, Moriarty Kieran, Newsome Philip, O'Grady John, Pryke Rachel, Rutter Harry, Ryder Stephen, Sheron Nick, Smith Tom

出版信息

Lancet. 2014 Nov 29;384(9958):1953-97. doi: 10.1016/S0140-6736(14)61838-9.

DOI:10.1016/S0140-6736(14)61838-9
PMID:25433429
Abstract
摘要

相似文献

1
Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis.应对英国的肝脏疾病：实现卓越医疗保健以及降低因过量饮酒、肥胖和病毒性肝炎等生活方式问题导致过早死亡的蓝图。
Lancet. 2014 Nov 29;384(9958):1953-97. doi: 10.1016/S0140-6736(14)61838-9.
2
Gathering momentum for the way ahead: fifth report of the Lancet Standing Commission on Liver Disease in the UK.蓄势前行：英国柳叶刀肝脏疾病常务委员会第五次报告。
Lancet. 2018 Dec 1;392(10162):2398-2412. doi: 10.1016/S0140-6736(18)32561-3. Epub 2018 Nov 22.
3
Liver disease in the UK: a Lancet Commission.英国的肝病：《柳叶刀》委员会报告
Lancet. 2013 Nov 9;382(9904):1537-8. doi: 10.1016/S0140-6736(13)62152-2.
4
Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: fourth report of the Lancet Standing Commission on Liver Disease in the UK.英国柳叶刀肝脏病学委员会关于过量饮酒、肥胖和病毒性肝炎导致的疾病负担和费用：第四次报告。
Lancet. 2018 Mar 17;391(10125):1097-1107. doi: 10.1016/S0140-6736(17)32866-0. Epub 2017 Nov 29.
5
Unacceptable failures: the final report of the Lancet Commission into liver disease in the UK.不可接受的失败：英国柳叶刀委员会关于肝脏疾病的最终报告。
Lancet. 2020 Jan 18;395(10219):226-239. doi: 10.1016/S0140-6736(19)32908-3. Epub 2019 Nov 29.
6
Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.英国的胃肠病学服务。疾病负担以及胃肠和肝脏疾病服务的组织与提供：证据综述
Gut. 2007 Feb;56 Suppl 1(Suppl 1):1-113. doi: 10.1136/gut.2006.117598.
7
Outcomes of Early Liver Transplantation for Patients With Severe Alcoholic Hepatitis.早期肝移植治疗重症酒精性肝炎患者的结局。
Gastroenterology. 2018 Aug;155(2):422-430.e1. doi: 10.1053/j.gastro.2018.04.009. Epub 2018 Apr 12.
8
The lottery of primary care for liver disease.肝病初级护理的随机性
Lancet Gastroenterol Hepatol. 2021 Oct;6(10):771. doi: 10.1016/S2468-1253(21)00315-0.
9
Alcohol Policies and Alcohol-related Liver Disease Mortality.酒精政策与酒精性肝病死亡率
Gastroenterology. 2021 Jul;161(1):350-352. doi: 10.1053/j.gastro.2021.03.031. Epub 2021 Mar 19.
10
Healthcare practitioners' experiences of an intervention to detect and treat patients with liver disease (the LOCATE intervention): a qualitative process evaluation.医疗保健从业者对一项旨在检测和治疗肝病患者的干预措施（LOCATE 干预）的体验：一项定性过程评估。
BMJ Open. 2019 May 22;9(5):e028591. doi: 10.1136/bmjopen-2018-028591.

引用本文的文献

1
The development of Liver Research Cymru, a new partnership to increase hepatology research activity in Wales.威尔士肝脏研究组织的发展，这是一个旨在增加威尔士肝脏病学研究活动的新合作项目。
NIHR Open Res. 2025 Aug 15;4:57. doi: 10.3310/nihropenres.13663.2. eCollection 2024.
2
Enhanced liver fibrosis test facilitates stratification of people with alcohol use disorder in primary care.增强型肝纤维化检测有助于在初级保健中对酒精使用障碍患者进行分层。
BMJ Open Gastroenterol. 2025 Aug 4;12(1):e001905. doi: 10.1136/bmjgast-2025-001905.
3
Prospective multicentre randomised controlled trial to assess the clinical effectiveness of the novel CirrhoCare digital therapeutic management system: a study protocol.评估新型CirrhoCare数字治疗管理系统临床有效性的前瞻性多中心随机对照试验：研究方案
BMJ Open. 2025 Jul 6;15(7):e098725. doi: 10.1136/bmjopen-2024-098725.
4
Effects of folic acid supplementation before conception on innate immunity and anti-HBs levels of offspring born to HBsAg-positive mothers.孕前补充叶酸对HBsAg阳性母亲所生后代先天免疫及抗-HBs水平的影响。
Front Nutr. 2025 Apr 23;12:1526053. doi: 10.3389/fnut.2025.1526053. eCollection 2025.
5
Identifying emergency presentations of chronic liver disease using routinely collected administrative hospital data.利用常规收集的医院管理数据识别慢性肝病的紧急情况。
JHEP Rep. 2024 Dec 31;7(5):101322. doi: 10.1016/j.jhepr.2024.101322. eCollection 2025 May.
6
Cirrhosis epidemiology in Denmark 1998-2022, and 2030 forecast.1998 - 2022年丹麦肝硬化流行病学及2030年预测。
JHEP Rep. 2025 Feb 8;7(5):101353. doi: 10.1016/j.jhepr.2025.101353. eCollection 2025 May.
7
Health inequalities in hepatocellular carcinoma surveillance, diagnosis, treatment, and survival in the United Kingdom: a scoping review.英国肝细胞癌监测、诊断、治疗及生存方面的健康不平等：一项范围综述
BJC Rep. 2025 Mar 3;3(1):13. doi: 10.1038/s44276-025-00126-5.
8
Current and emerging therapies for alcohol-associated hepatitis.酒精性肝炎的现有及新兴疗法
Liver Res. 2023 Mar 15;7(1):35-46. doi: 10.1016/j.livres.2023.03.002. eCollection 2023 Mar.
9
Incidence rate and associated patient characteristics of liver disease in Wales 2004-2022: a retrospective population-scale observational study.2004 - 2022年威尔士肝病的发病率及相关患者特征：一项回顾性人群规模观察性研究。
BMJ Open. 2025 Feb 10;15(2):e093335. doi: 10.1136/bmjopen-2024-093335.
10
Gene editing enables non-invasive PET imaging of human induced pluripotent stem cell-derived liver bud organoids.基因编辑实现了对人诱导多能干细胞衍生的肝芽类器官的无创正电子发射断层扫描（PET）成像。
Mol Ther Methods Clin Dev. 2025 Jan 7;33(1):101406. doi: 10.1016/j.omtm.2025.101406. eCollection 2025 Mar 13.